{"id":130840,"date":"2021-11-18T23:25:41","date_gmt":"2021-11-19T07:25:41","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2021\/11\/israeli-oral-covid-vaccine-heads-to-mexico-aims-to-fast-track-approval"},"modified":"2021-11-18T23:25:41","modified_gmt":"2021-11-19T07:25:41","slug":"israeli-oral-covid-vaccine-heads-to-mexico-aims-to-fast-track-approval","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2021\/11\/israeli-oral-covid-vaccine-heads-to-mexico-aims-to-fast-track-approval","title":{"rendered":"Israeli oral COVID vaccine heads to Mexico, aims to fast-track approval"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/israeli-oral-covid-vaccine-heads-to-mexico-aims-to-fast-track-approval.jpg\"><\/a><\/p>\n<p>Oramed Pharmaceuticals, the developer of the Oravax oral COVID-19 vaccine candidate, has announced a partnership with Mexico\u2019s Genomma Lab Internacional to help fast-track a Phase II clinical trial and gain emergency use authorization in the Latin American country.<\/p>\n<hr>\n<p>Only about 58% of Mexico\u2019s population has been jabbed with one dose of a coronavirus vaccine, averaging around 4,500 new cases per day.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Oramed Pharmaceuticals, the developer of the Oravax oral COVID-19 vaccine candidate, has announced a partnership with Mexico\u2019s Genomma Lab Internacional to help fast-track a Phase II clinical trial and gain emergency use authorization in the Latin American country. Only about 58% of Mexico\u2019s population has been jabbed with one dose of a coronavirus vaccine, averaging [\u2026]<\/p>\n","protected":false},"author":534,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-130840","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/130840","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/534"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=130840"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/130840\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=130840"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=130840"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=130840"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}